J. Ford
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments 13
- Iron Metabolism and Disorders 10
- Genetics top 0.1%
- Hemoglobinopathies and Related Disorders 12
- Chronic Lymphocytic Leukemia Research 11
- Rheumatology top 0.2%
- Eosinophilic Disorders and Syndromes 7
- Oncology top 1%
- Bone health and treatments 15
- Gastroenterology top 1%
-
- Medical Imaging and Pathology Studies 7
-
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Brian DrukerRenaud CapdevilleCharles L. SawyersDebra RestaMoshe TalpazHagop M. KantarjianBin PengElisabeth Buchdunger
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
J. Ford
57 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Hematology 4.9k
- Genetics 3.4k
- Rheumatology 2.2k
- Oncology 2.3k
- Gastroenterology 434
Countries citing papers authored by J. Ford
This map shows the geographic impact of J. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ford more than expected).
Fields of papers citing papers by J. Ford
This network shows the impact of papers produced by J. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ford. The network helps show where J. Ford may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 15 | |
| 3 | 2016 | 33 | |
| 4 | 2015 | 176 | |
| 5 | 2008 | 34 | |
| 6 | 2008 | 12 | |
| 7 | 2005 | 10 | |
| 8 | 2003 | 121 | |
| 9 | 2003 | 82 | |
| 10 | 2002 | 37 | |
| 11 | Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome | 2001 | 9 |
| 12 | Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosomebreakdown → | 2001 | 2070 |
| 13 | Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemiabreakdown → | 2001 | 3811 |
| 14 | 1998 | 33 | |
| 15 | 1998 | 83 | |
| 16 | 1996 | 3 | |
| 17 | 1995 | 112 | |
| 18 | 1992 | 61 | |
| 19 | 1992 | 60 | |
| 20 | 1981 | 3 |
About J. Ford
J. Ford is a scholar working on Hematology, Genetics and Oncology, having authored 58 papers that have together received 8.6k indexed citations. Recurring topics across this work include Bone health and treatments (15 papers), Chronic Myeloid Leukemia Treatments (13 papers), Hemoglobinopathies and Related Disorders (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Iron Metabolism and Disorders (10 papers), Medical Imaging and Pathology Studies (7 papers), Eosinophilic Disorders and Syndromes (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Hematology (4.9k citations), Genetics (3.4k citations) and Rheumatology (2.2k citations). J. Ford has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Brian Druker, Renaud Capdeville, Charles L. Sawyers, Debra Resta, Moshe Talpaz, Hagop M. Kantarjian, Bin Peng, Elisabeth Buchdunger, Nicholas Lydon and Sayuri Ohno-Jones. Their work appears in journals such as Blood, British Journal of Cancer, The Breast, Journal of Clinical Oncology and Seminars in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.